(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RENALPURE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RENALPURE

ST13

US500000076539654

Class

1, 5

Filing

76539654

Registration

3029776

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

07/28/2026

Trademark type

Word

Nice classes

1, 5

Filing date

08/25/2003

Registration date

12/13/2005

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/09/2026

Last transaction

07/28/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/07/2004

First use in commerce

06/07/2004

Drawing code

1

Owner type

03

Owner location

WIXOM, MI, US

Examiner

WOOD, CAROLINE

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ROCKWELL MEDICAL, INC.
Rockwell Medical Technologies, Inc.

Representatives

Matthew J. Gipson PRICE HENEVELD LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

CHEMICALSACIDS AND BICARBONATES IN LIQUID AND POWDER FORM FOR USE IN THE MANUFACTURE OF DIALYSATE FOR HEMODIALYSIS

Class 5

DIALYSATE COMPOUNDS FOR HEMODIALYSIS

Publications

History of USPTO decisions and trademark events.

39 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/09/2026

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

07/09/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/09/2026

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

07/06/2026

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

02/18/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/18/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

11/17/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/13/2024

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/12/2015

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/12/2015

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/12/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/12/2015

E89R

TEAS SECTION 8 & 9 RECEIVED

05/21/2015

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/18/2015

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED

08/31/2011

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/31/2011

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

08/31/2011

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/31/2011

MAIL

PAPER RECEIVED

07/19/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

12/13/2005

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

10/24/2005

ALIE

ASSIGNED TO LIE

10/21/2005

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/20/2005

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/20/2005

MAIL

PAPER RECEIVED

09/01/2005

IUAF

USE AMENDMENT FILED

08/29/2005

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

03/22/2005

PUBO

PUBLISHED FOR OPPOSITION

12/28/2004

NPUB

NOTICE OF PUBLICATION

12/08/2004

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/27/2004

ALIE

ASSIGNED TO LIE

10/22/2004

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/19/2004

ACEC

AMENDMENT FROM APPLICANT ENTERED

09/23/2004

IUFF

USE AFFIDAVIT FAILED FORMALITIES

09/23/2004

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/10/2004

IUAF

USE AMENDMENT FILED

09/10/2004

MAIL

PAPER RECEIVED

09/10/2004

CNRT

NON-FINAL ACTION MAILED

03/05/2004

DOCK

ASSIGNED TO EXAMINER

03/02/2004

Continuous trademark protection

Get notified about every new filing that threatens RENALPURE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.